lung cancer
Conditions
Interventions
Gold Standard:The "gold standard" to determine lung cancer in this study is histopathology.
Index test:PCR 
was 
used 
to 
and 
the 
of 
serum 
in 
lung 
cancer 
patients 
Sponsors
Shanghai Pulmonary Hospital, Tongji University School of Medicine
Eligibility
Sex/Gender
All
Age
18 Years to 80 Years
Inclusion criteria
Inclusion criteria: 1. Voluntarily participate in clinical research; fully understand and inform this research and sign an informed consent form (ICF); be willing to follow and have the ability to complete all experimental procedures; 2. Male or female aged 18-80 years (inclusive) when signing the ICF. ; 3. All patients included in the analysis had cancer cells found by pathology before or after surgery, and were confirmed to be lung cancer by immunohistochemistry; 4. The patient has not received any systemic therapy related to malignant tumor in the past; 5. Patients must provide qualified plasma samples for microRNA expression level determination; 6. Relevant laboratory tests suggest that they can tolerate radical lung cancer surgery.
Exclusion criteria
Exclusion criteria: 1. Patients with unclear diagnosis of lung cancer; 2. Patients with contraindications to surgery; 3. Suffering from other active malignant tumors within the year or at the same time. Localized tumors that have been cured, such as basal cell carcinoma of the skin, squamous cell carcinoma of the skin, superficial bladder cancer, carcinoma in situ of the prostate, carcinoma in situ of the cervix, and carcinoma in situ of the breast can be enrolled; 4. Human immunodeficiency virus (HIV) infection; 5. Patients with active pulmonary tuberculosis; 6. Received treatment with live vaccines within 28 days before the first dose. However, inactivated viral vaccines are allowed to treat seasonal influenza, but intranasal live attenuated influenza vaccines are not allowed; 7. Women who are pregnant or breastfeeding; 8. The patient has a known history of psychotropic substance abuse or drug abuse; the patient has a history of alcoholism; 9. According to the judgment of the investigator, the patient has other factors that may lead to the early termination of this study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Sensitivity;Specificity; | — |
Countries
China
Contacts
Public ContactZhu Yuming
Shanghai Pulmonary Hospital
Outcome results
None listed